Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.
Anthem Blue Cross and Blue Shield has renewed its push to bring online care to the Indiana market, including video. It has asked the state’s Medical Licensing Board to relax a 2003 rule that stands in its way.
Eli Lilly and Co.’s board is once again recommending the removal of a provision that makes the company an almost impossible target for hostile takeovers. The same proposal has fallen slightly short at each of the past two annual shareholder meetings.
Rolls-Royce Corp. plans to invest $42 million to set up a new manufacturing plant in Indianapolis and create 100 jobs by 2014, the company announced Tuesday morning.
Spurred by fundraising campaigns by local television stations, more than $1 million has been raised to help victims of last week’s devastating tornadoes in southern Indiana. In addition to doing a good thing, the stations are getting a marketing boost from their efforts.
Deron Kintner has stepped up to fund a string of high-profile real estate projects at a time when private-sector financing is scarce.
The winners’ mission will be to launch successful charter schools and replicate those schools at three or four additional locations around Indianapolis.
Hunger-fighting charities hope to tap volunteers and resources for special projects through a new entity, the Indy Hunger Network.
Indianapolis Airport Authority CEO John Clark and two key officers spent more than $67,000 last year on travel that included extended business trips to Brazil, Denmark, Greece, Morocco and Switzerland.
Conner Prairie President and CEO Ellen Rosenthal has brought to the Fishers museum her passion for creating great visitor experiences.
Jan Lundberg, Eli Lilly and Co.’s executive vice president of science and technology, discussed the Indianapolis-based drugmaker’s latest efforts to improve its research and development efforts.
Melissa Kelly and Zach Pierson, who opened delivery service Grateful Pet LLC in July and are bootstrapping the business through Kelly’s day job.
Indianapolis-based Eli Lilly and Co discovers, develops, manufactures and sells pharmaceutical products for humans and animals.
Decision by industry giant Pfizer Inc. to abandon its generic insulin project is good news for Eli Lilly and Co.
Indianapolis-based Eli Lilly and Co. will introduce “over a dozen” new products in China in the next five years, focusing on “unmet needs” such as cancer and diabetes, CEO John Lechleiter said this week.
European regulators have approved an expanded use for the diabetes treatment Byetta, developed by Eli Lilly and Co. and Amylin Pharmaceuticals Inc. The FDA approved the same expanded use last fall.
An Interstate 70 ramp in downtown Indianapolis is expected to be shut down for several days so that a 40-foot metal sculpture of a molecule can be built.
